Verition Fund Management LLC Neogenomics Inc Transaction History
Verition Fund Management LLC
- $21.7 Billion
- Q3 2025
A detailed history of Verition Fund Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 257,012 shares of NEO stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
257,012
Previous 219,139
17.28%
Holding current value
$2.66 Million
Previous $1.6 Million
23.92%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding NEO
# of Institutions
290Shares Held
131MCall Options Held
1.3MPut Options Held
395K-
Black Rock Inc. New York, NY19.7MShares$203 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$144 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN9.93MShares$103 Million9.2% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD8.22MShares$85 Million2.48% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$61.8 Million0.02% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.3B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...